Form 4: Guardant Health Executive Kumud Kalia Reports Stock Option and Restricted Stock Unit Awards

Chief Information Officer Kumud Kalia reports the acquisition of stock options and restricted stock units in Guardant Health, Inc.

Summary

• On March 12, 2025, Kumud Kalia, Chief Information Officer of Guardant Health, Inc., was granted stock options for 24,363 shares at an exercise price of $43.10.
• These options vest over a three-year period, with 33% vesting on April 1, 2026, and the remaining 67% vesting in equal monthly installments over the subsequent two years.
• Kalia also received 16,242 restricted stock units (RSUs) that vest over a three-year period, with 33% vesting on April 1, 2026, and the remaining 67% vesting in equal quarterly installments over the following two years.
• Following these transactions, Kalia directly owns 24,363 stock options and 16,242 restricted stock units.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive as it reflects standard executive compensation practices, indicating confidence in the company's future.

Positives

• The grant of stock options and RSUs to the Chief Information Officer aligns their interests with the long-term success of Guardant Health.
• The vesting schedule encourages continued service and contribution to the company over a three-year period.

Future Outlook

The document does not contain any specific forward-looking statements about the company's future performance.

Industry Context

This type of equity compensation is standard practice in the biotech industry to incentivize key executives and align their interests with shareholders.

Comparison to Industry Standards

• Stock option and RSU grants are common forms of executive compensation in the biotechnology and healthcare industries.
• Companies like Illumina, Roche, and Thermo Fisher Scientific also utilize similar equity-based compensation plans to attract and retain talent.
• The vesting schedules described are fairly standard, aligning with typical industry practices for incentivizing long-term performance.

Stakeholder Impact

• Shareholders may view the equity grants as a positive sign, aligning management's interests with the company's long-term success.
• Employees may see this as a positive indicator of the company's commitment to its leadership team.

Key Dates